{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:11:46Z","timestamp":1792127506588,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.jaad.2011.06.004","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T11:35:00Z","timestamp":1311680100000},"page":"767-770","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":66,"title":["The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: Experience in 19 patients"],"prefix":"10.1016","volume":"66","author":[{"given":"Andrew B.","family":"Zimmerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarina B.","family":"Elmariah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Soter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2011.06.004_bib1","series-title":"Fitzpatrick\u2019s Dermatology in General Medicine","first-page":"1409","article-title":"Urticaria and angioedema","author":"Soter","year":"2003"},{"key":"10.1016\/j.jaad.2011.06.004_bib2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0190-9622(99)70495-0","article-title":"Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-Fc\u03b5RI and anti-IgE autoantibodies","volume":"40","author":"Sabroe","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2011.06.004_bib3","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1111\/j.1365-4632.2006.02655.x","article-title":"Treatment of severe chronic idiopathic urticaria with oral mycophenolate mofetil in patients not responding to antihistamines and\/or corticosteroids","volume":"45","author":"Shahar","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2011.06.004_bib4","unstructured":"IBT Reference Laboratory; Lenexa (KS). CU index test. Available\u00a0from: URL:http:\/\/www.ibtlabs.com\/derm\/pdf\/CU_Test_rev_041609.pdf. Accessed March 10, 2011."},{"key":"10.1016\/j.jaad.2011.06.004_bib5","unstructured":"Quest Diagnostics; San Juan Capistrano (CA). Histamine release (chronic urticaria) test. Available from: URL: http:\/\/www.questdiagnostics.com\/hcp\/testmenu\/jsp\/showTestMenu.jsp?fn=16838.html&labCode=SJC. Accessed March 10, 2011."},{"key":"10.1016\/j.jaad.2011.06.004_bib6","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jaci.2006.02.016","article-title":"Chronic urticaria sera increase basophil CD203c expression","volume":"117","author":"Yasnowsky","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2011.06.004_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00403-005-0586-4","article-title":"The effectiveness of montelukast for the treatment of antihistamine-resistant chronic urticaria","volume":"297","author":"Sanada","year":"2005","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2011.06.004_bib8","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1111\/j.1365-2222.2004.02019.x","article-title":"Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study","volume":"34","author":"Nettis","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaad.2011.06.004_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaci.2003.10.002","article-title":"The addition of zafirlukast to cetirizine improves the treatment of chronic urticaria in patients with positive autologous serum skin test results","volume":"113","author":"Bagenstose","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2011.06.004_bib10","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0091-6749(98)70032-6","article-title":"Successful treatment of chronic urticaria with leukotriene antagonists","volume":"102","author":"Ellis","year":"1998","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2011.06.004_bib11","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/0091-6749(86)90232-0","article-title":"Efficacy of doxepin in the treatment of chronic idiopathic urticaria","volume":"78","author":"Goldsobel","year":"1986","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2011.06.004_bib12","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/0091-6749(89)90011-0","article-title":"Therapy of chronic idiopathic urticaria with nifedipine: demonstration of beneficial effect in a double-blinded, placebo-controlled, crossover trial","volume":"83","author":"Bressler","year":"1989","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2011.06.004_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0889-8561(22)00815-3","article-title":"Chronic urticaria as a manifestation of the late phase reaction","volume":"15","author":"Zaradac","year":"1995","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.jaad.2011.06.004_bib14","first-page":"254","article-title":"Low-dose dapsone in chronic idiopathic urticaria: preliminary results of an open study","volume":"85","author":"Cassano","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2011.06.004_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1468-3083.2007.02510.x","article-title":"Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs antihistamine in patients with chronic idiopathic urticaria","volume":"22","author":"Engin","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2011.06.004_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1444-0903.2004.00532.x","article-title":"Impact of hydroxychloroquine therapy on chronic urticaria: chronic autoimmune urticaria study and evaluation","volume":"34","author":"Reeves","year":"2004","journal-title":"Intern Med J"},{"key":"10.1016\/j.jaad.2011.06.004_bib17","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archderm.142.10.1337","article-title":"Successful treatment of recalcitrant chronic idiopathic urticaria with sulfasalazine","volume":"142","author":"McGirt","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2011.06.004_bib18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.2009.09538.x","article-title":"Methotrexate: a useful steroid-sparing agent in recalcitrant chronic urticaria","volume":"162","author":"Perez","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2011.06.004_bib19","first-page":"285","article-title":"Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: clinical and immunological evaluation","volume":"24","author":"Di Gioacchino","year":"2003","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaad.2011.06.004_bib20","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1398-9995.1997.tb00996.x","article-title":"Low-dose cyclosporin A in the treatment of severe chronic idiopathic urticaria","volume":"52","author":"Toubi","year":"1997","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2011.06.004_bib21","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1398-9995.2010.02419.x","article-title":"Cyclosporine-A in severe chronic urticaria: the option for long-term therapy","volume":"65","author":"Kessel","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2011.06.004_bib22","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jaad.2006.04.078","article-title":"Cyclosporine in chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial","volume":"55","author":"Vena","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2011.06.004_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2011.06.004_bib24","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jaci.2010.05.047","article-title":"Effective treatment of therapy-resistant chronic spontaneous urticaria with omalizumab","volume":"126","author":"Magerl","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2011.06.004_bib25","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/0140-6736(92)90666-Q","article-title":"Plasmapheresis for severe, unremitting, chronic urticaria","volume":"339","author":"Grattan","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2011.06.004_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000090656","article-title":"Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial","volume":"212","author":"Staubach","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2011.06.004_bib27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.anai.2009.12.007","article-title":"Effect of high-dose intravenous immunoglobulin treatment in therapy-resistant chronic spontaneous urticaria","volume":"104","author":"Mitzel-Kaoukhov","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2011.06.004_bib28","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2133.1998.02033.x","article-title":"Intravenous immunoglobulin in autoimmune chronic urticaria","volume":"138","author":"O\u2019Donnell","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2011.06.004_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaad.2008.08.049","article-title":"Mycophenolate mofetil in dermatology","volume":"60","author":"Orvis","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2011.06.004_bib30","first-page":"741","article-title":"Long-term safety of mycophenolate mofetil and cyclosporine: a review","volume":"7","author":"Buell","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2011.06.004_bib31","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2165\/00002018-200124090-00002","article-title":"Adverse gastrointestinal effects of mycophenolate mofetil: etiology, incidence and management","volume":"24","author":"Behrend","year":"2001","journal-title":"Drug Safety"},{"key":"10.1016\/j.jaad.2011.06.004_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.5414\/CNP60119","article-title":"Four cases of red blood cell aplasia in association with the use of mycophenolate mofetil in renal transplant patients","volume":"60","author":"Engelen","year":"2003","journal-title":"Clin Nephrol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211006311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211006311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:23:05Z","timestamp":1759270985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962211006311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0190962211006311"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2011.06.004","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.12814956.14096054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.12814956.14877060","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of mycophenolate mofetil for the treatment of autoimmune and chronic idiopathic urticaria: Experience in 19 patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2011.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}